Furosemide and Erythema multiforme - a phase IV clinical study of FDA data

Summary:

Erythema multiforme is found among people who take Furosemide, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Furosemide and have Erythema multiforme. It is created by eHealthMe based on reports of 274,621 people who have side effects when taking Furosemide from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Aug, 20, 2023

274,621 people reported to have side effects when taking Furosemide.
Among them, 1,689 people (0.62%) have Erythema multiforme.

What is Furosemide?

Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 276,909 Furosemide users for its effectiveness, alternative drugs and more.

What is Erythema multiforme?

Erythema multiforme (a type of hypersensitivity reaction) is found to be associated with 2,947 drugs and 2,835 conditions by eHealthMe.

Number of Furosemide and Erythema multiforme reports submitted per year:

Could Furosemide cause Erythema multiforme?

* Approximation only. Some reports may have incomplete information.

Do you take Furosemide and have Erythema multiforme?

Check whether Erythema multiforme is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Ochoa PS, Fisher T, "A 7‐Year Case of Furosemide‐Induced Immune Thrombocytopenia", Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013 Jul .
Tognetti L, Giorgini S, Lotti T, "Erythema multiforme-like eruption from a slimming drug preparation cutaneous adverse drug reaction", Indian dermatology online journal, 2011 Jan .

Related studies

How severe was Erythema multiforme and when was it recovered:

Erythema multiforme in Furosemide

Expand to all the drugs that have ingredients of furosemide:

Erythema multiforme and drugs with ingredients of furosemide (3,068 reports)

Alternative drugs to, pros and cons of Furosemide:

Furosemide (276,909 reports)

Common Furosemide side effects:

Breathing difficulty: 20,650 reports
Fatigue (feeling of tiredness): 14,970 reports
Diarrhea: 13,530 reports
Hypotension (abnormally low blood pressure): 13,476 reports
Weakness: 13,137 reports
Pneumonia: 13,078 reports

Browse all side effects of Furosemide:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Erythema multiforme treatments and more:

Erythema multiforme (51,191 reports)

COVID vaccines that are related to Erythema multiforme:

Common drugs associated with Erythema multiforme:

All the drugs that are associated with Erythema multiforme:

Erythema multiforme (2,947 drugs)

Common conditions associated with Erythema multiforme:

High blood pressure: 2,546 reports
Epilepsy: 1,791 reports
Fever: 1,545 reports
Pain: 1,525 reports
Depression: 1,255 reports

All the conditions that are associated with Erythema multiforme:

Erythema multiforme (2,835 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on furosemide (the active ingredients of Furosemide) and Furosemide (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.